Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Maintenance and Second-Line Decisions in CRC

February 26th 2018

Frontline Antibody Selection in Metastatic CRC

February 26th 2018

Left- Versus Right-Sided Tumors in CRC

February 26th 2018

Importance of HER2 Expression in CRC

February 26th 2018

Role of Molecular Testing in CRC Management

February 26th 2018

Early-Onset CRC: What Do We Know?

February 26th 2018

Treating Liver or Peritoneal Metastases in CRC

February 26th 2018

Managing Patients After Adjuvant Therapy

February 26th 2018

Duration of Adjuvant Therapy: CRC Subsets

February 26th 2018

Deciding on Adjuvant Therapy in CRC

February 26th 2018

Biomarkers and Novel Approaches in CRC

February 17th 2018

Reverce Study: Outcomes and Impact

February 17th 2018

Sequencing of Therapy in Refractory mCRC

February 17th 2018

Management of Side Effects With TAS-102

February 17th 2018

Proactive Side Effect Management With Regorafenib

February 17th 2018

Clinical Implications of the ReDOS Findings

February 17th 2018

The Regorafenib Dose Optimization Study

February 17th 2018

Treatment Options in Refractory mCRC

February 17th 2018

Treatment Goals in Refractory mCRC

February 17th 2018

Effective Management of CINV Improves Response to Treatment

January 26th 2018

The goal of selecting optimal antiemetic therapy continues to be a moving target with the emergence of newer agents and patient-related risk factors, as well as the rapid evolution of guidelines for the management of chemotherapy-induced nausea and vomiting.

NEXT PAGE
PREVIOUS PAGE